AHRQ

Dear Research Advocate, The two-month reprieve from sequestration agreed to as part of the ’€œdeal’€ to avert the fiscal cliff is a partial victory for all who worked hard to save research, giving us much-needed additional time to make our case. We need be smart in using that time well, because the delay was paid for through a combination of new revenue and spending cuts that could further drain the pool of dollars used to fund research. The fact that many conservative members of Congress expressed outrage that the fiscal cliff deal didn’€™t include larger spending cuts underscores this point. The debt ceiling will need to be raised within the next two months, adding fuel to the fire. And...
So it’s not a big deal if patients skip a pill or two? On the contrary. Several studies have looked at the issue and the range of their findings is exceptionally broad. One thing that cannot be disputed: The cost is extraordinary. On the low end of the range, the lack of adherence to medications costs the U.S. health care system $100 billion annually in direct costs. The high end: $289 billion. The reasons are obvious: In the absence of therapies, diseases and conditions aren’t slowed or defeated. So the Agency for Healthcare Research and Quality took a look at a number of academic studies to determine if anything could be gleaned from an overview of interventions. Indeed, there are ’€” but...
Dear Research Advocate, As you know, the Republican Party Platform was unveiled Tuesday during the convention in Tampa. There are direct references to medical and health research and other statements that ’€” if not explicit ’€” definitely imply the need for such research. We can draw from both to enhance our advocacy efforts. The following exemplifies the direct and indirect nature of the platform’€™s embrace of medical and health research: ’€œWe support federal investment in health care delivery systems and solutions creating innovative means to provide greater, more cost-effective access to high quality health care. We also support federal investment in basic and applied biomedical...
WASHINGTON’€”August 7, 2012 ’€” Research!America, a nonprofit advocacy alliance, says too many congressional candidates are minimizing the importance of our nation’€™s faltering role in fighting deadly and disabling diseases as a campaign issue. Polling indicates that Americans rank medical research a high priority but also shows a majority of likely voters are not aware of their representatives’€™ views on research. Some candidates have indicated that they ’€œdon’€™t have time’€ to fill out a short questionnaire gauging their views on the importance of continued medical progress. Research!America and its partner organizations are calling on candidates to elevate the fight to save lives in...
Dear Research Advocate, Just before leaving Washington for five weeks, Congressional leaders Harry Reid and John Boehner announced agreement on a continuing resolution (’€œC.R.’€) to fund the government until March 2013. In what has become routine, appropriations decisions will be deferred far beyond the October 1 beginning of the federal fiscal year. The leaders’€™ agreement, motivated by the need to avert a government shutdown, would leave NIH, FDA, AHRQ, CDC and the NSF with steady-state budgets, which is at least a better outcome than proposals for cuts pending before the House right now. But don’€™t take your eye off the ball! All kinds of mischief is possible between now and March,...
Dear Research Advocate, Sequestration, the looming fiscal cliff, a dangerous House appropriations bill ’€“ all were addressed in our members-only call yesterday with Chairman John Porter. As Porter pointed out, we have to keep the big picture in mind, pushing for tax and entitlement reform as part of the larger ’€œfix,’€ AND, in the immediate, we have to cry foul about the House bill and sequestration. Right now, while Congress is still in session, we must flood their offices, and the Administration, with calls and e-mails. Take 30 seconds to send a message to your representatives to remind them that medical research should be among our nation’€™s highest priorities. And – as was...
Dear Research Advocate, ’€œShell-shocked’€ is a fair way to describe reaction to the latest appropriations bill in which the House Labor, Health and Human Services, Education and Related Agencies subcommittee released its funding recommendations. The NIH was flat-funded and seriously micromanaged in unprecedented ways, CDC funding was cut deeply, and funding for the Agency for Healthcare Research and Quality (AHRQ) was terminated . See our press statement on the bill here and the Nature article that included our quote. The Science Insider article also has details. As if this wasn’€™t bad enough, an amendment to the subcommittee bill would have slashed another $8.3 billion ’€“ fortunately...
Research!America President and CEO Mary Woolley released a statement, saying that a House appropriations subcommittee bill places the health and well-being of Americans in jeopardy: “How can Congress justify the elimination of a critical health agency and severe cuts to other programs under the House Labor-HHS-Education appropriations subcommittee bill? We cannot afford to zero out funding for the Agency for Healthcare Research and Quality (AHRQ) at a time when it is addressing medical errors that kill more than 100,000 people a year and accelerating patient access to the best medical practices. We cannot afford to slash the Centers for Disease Control and Prevention (CDC) budget when it...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient